人福医药 (600079)

Humanwell Healthcare (Group) Co., Ltd.

ASH

Tags

SSE 380 IndexArtificial Intelligence (AI)Generic DrugsInnovative DrugsChemical PharmaceuticalsPharmaceutical ManufacturingPharmaceuticals and HealthcareInvestments in Financial InstitutionsControl ChangePrivate HospitalsBiological VaccinesHigh-Performing StocksVitaminsHepatitis ConceptMargin Trading and Securities LendingNon-Cyclical StocksHigh Accounts Receivable

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

  • Total Shares(W): 163222.60
  • Circulating A-Shares(W): 154317.88
  • Earnings Per Share(RMB): 1.0300
  • Net Assets Per Share(RMB): 11.5877
  • Operating Revenue(W RMB): 1788335.25
  • Total Profit(W RMB): 263166.06
  • **Net Profit Attributable to Parent(W RMB) **: 168857.65
  • Net Profit Growth Rate(%): 6.22
  • Weighted Return on Equity(%): 9.2000
  • Operating Cash Flow Per Share(RMB): 1.0100
  • Undistributed Profit Per Share(RMB): 6.5889
  • Capital Reserve Per Share(RMB): 3.4830

2. Main Business

The main business covers:

  • Production, research and development, and sales of pharmaceutical industry products

3. Company Basic Information

  • Company Name: Humanwell Healthcare Group Co., Ltd.
  • Listing Date: 1997-06-06
  • Industry: Pharmaceutical Manufacturing
  • Address: No. 666 Gaoxin Avenue, East Lake High-tech Development Zone, Wuhan, Hubei Province
  • Website: https://www.humanwell.com.cn
  • Company Profile: The company was jointly established in March 1993 by three companies including China Humanwell New Technology Development Center. It started with 30.30 million sponsor shares converted from cash and other assets, and raised 1.20 million corporate shares and 6.00 million employee shares. After the issuance on May 22, 1997, the total share capital at the time of listing reached 57.50 million shares. The employee shares became tradable on the Shanghai Stock Exchange three years after the 20.00 million public shares started trading on June 6, 1997.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 COFCO Trust Co., Ltd. - COFCO Trust - Chunni No. 1 Bankruptcy Restructuring Service Trust Asset Management Plan 19090.03 12.37
2 China Merchants Biotech Investment Development (Wuhan) Partnership (Limited Partnership) General Legal Person 9793.36 6.35
3 China Merchants Life Science and Technology (Wuhan) Co., Ltd. General Legal Person 7332.95 4.75
4 Hong Kong Securities Clearing Company Ltd. Northbound Capital 4218.32 2.73
5 Wuhu Xinfu Equity Investment Partnership (Limited Partnership) General Legal Person 2828.24 1.83
6 Wuhan High-tech State-owned Holding Group Co., Ltd. General Legal Person 2618.72 1.70
7 Penghua Jiangxin Jingxuan Mixed Securities Investment Fund Class A Fund 2347.22 1.52
8 Ping An Anying Stock-type Pension Product - Bank of China Limited General Legal Person 1741.88 1.13
9 Harvest Emerging Industries Stock Securities Investment Fund Fund 1311.27 0.85
10 Harvest Core Growth Mixed Securities Investment Fund Class A Fund 1074.84 0.70

5. Concept Sectors

  • Biological Vaccine
  • Private Hospital
  • Vitamin
  • Artificial Intelligence
  • Generic Drug
  • Hepatitis Concept
  • Innovative Drug

Remarks

  • Data update date: 2025-09-30
  • Data source: Public Market Information